Beam Therapeutics Inc. financial data

Symbol
BEAM on Nasdaq
Location
26 Landsdowne Street, Cambridge, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 4, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 647 % +10.6%
Debt-to-equity 36.3 % -25%
Return On Equity -42.9 % -164%
Return On Assets -31.5 % -188%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 101M shares +22.5%
Common Stock, Shares, Outstanding 101M shares +22.8%
Entity Public Float 1.91B USD -9.48%
Common Stock, Value, Issued 1.01M USD +22.8%
Weighted Average Number of Shares Outstanding, Basic 103M shares +24.5%
Weighted Average Number of Shares Outstanding, Diluted 103M shares +24.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 55.7M USD -84.1%
Research and Development Expense 412M USD +1.38%
General and Administrative Expense 110M USD -12.6%
Operating Income (Loss) -466M USD -155%
Nonoperating Income (Expense) 51.6M USD +27.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -113M USD -16.6%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -415M USD -189%
Earnings Per Share, Basic -4 USD/shares -180%
Earnings Per Share, Diluted -4 USD/shares -180%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 268M USD +16.4%
Marketable Securities, Current 807M USD +16%
Cash, Cash Equivalents, and Short-term Investments 1.1B USD +18.8%
Assets, Current 1.1B USD +16.2%
Property, Plant and Equipment, Net 108M USD -4.59%
Operating Lease, Right-of-Use Asset 97M USD -7.36%
Other Assets, Noncurrent 593K USD -45%
Assets 1.31B USD +11.9%
Accounts Payable, Current 9.55M USD +150%
Employee-related Liabilities, Current 16.5M USD +20.3%
Contract with Customer, Liability, Current 110M USD +23.5%
Liabilities, Current 183M USD +9.81%
Contract with Customer, Liability, Noncurrent 10.2M USD -82.4%
Operating Lease, Liability, Noncurrent 139M USD -6.97%
Other Liabilities, Noncurrent 266K USD -44.7%
Liabilities 345M USD -9.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 790K USD -55.1%
Retained Earnings (Accumulated Deficit) -1.89B USD -28.1%
Stockholders' Equity Attributable to Parent 966M USD +22.1%
Liabilities and Equity 1.31B USD +11.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -104M USD -4.15%
Net Cash Provided by (Used in) Financing Activities 473M USD +16240%
Net Cash Provided by (Used in) Investing Activities -125M USD -134%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 101M shares +22.8%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 244M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 275M USD +16%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 438M USD +33.1%
Deferred Tax Assets, Gross 469M USD +28%
Operating Lease, Liability 161M USD -6.52%
Depreciation 22.1M USD +1.03%
Payments to Acquire Property, Plant, and Equipment 3.07M USD +25.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -416M USD -197%
Lessee, Operating Lease, Liability, to be Paid 228M USD -9.38%
Property, Plant and Equipment, Gross 197M USD +9.28%
Operating Lease, Liability, Current 12.7M USD -1.92%
Lessee, Operating Lease, Liability, to be Paid, Year Two 22.5M USD -11%
Lessee, Operating Lease, Liability, to be Paid, Year One 24.4M USD -2.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 66.3M USD -15.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 23.2M USD +2.8%
Deferred Tax Assets, Operating Loss Carryforwards 49M USD +1137%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 23.4M USD +0.94%
Additional Paid in Capital 2.86B USD +26.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 5.53M USD +1.79%
Share-based Payment Arrangement, Expense 104M USD -8%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%